Corrigendum

Neuropsychopharmacology (2004) 29, 1762. doi:10.1038/sj.npp.1300448

Diminished GABAA Receptor Binding Capacity and a DNA Base Substitution in a Patient with Treatment-Resistant Depression and Anxiety

Markus Kosel, Uwe Rudolph, Peter Wielepp, Martin Luginbuhl, Wolfgang Schmitt, Hans U Fisch and Thomas E Schlaepfer

Correction to: Neuropsychopharmacology (2004) 29, 347–350. doi:10.1038/sj.npp.1300353

Following publication of the above paper, the author has identified an error with the legend for Figure 1. The legend should be read as follows:

Figure 1 Bispectral indices in the index patient (red line 0.3 mg etomidate/kg body weight) and a control (blue line, 0.25 mg etomidate/kg body weight). At time point 0 min, etomidate was administered. Horizontal bars indicate the time periods of loss of responsiveness of the index patient and the control to verbal commands. After loss of responsiveness to verbal commands, 0.75 mg succinylcholine/kg body weight was administered.

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Location and function of linker histones

Nature Structural Biology News and Views (01 Dec 1998)

Extra navigation

.
ADVERTISEMENT